AroCell AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was SEK 10.4 million compared to SEK 6.03 million a year ago. Net loss was SEK 11.07 million compared to SEK 17.52 million a year ago. Basic loss per share from continuing operations was SEK 0.05 compared to SEK 0.2 a year ago. Diluted loss per share from continuing operations was SEK 0.05 compared to SEK 0.2 a year ago.
For the nine months, sales was SEK 24.52 million compared to SEK 6.1 million a year ago. Net loss was SEK 42.45 million compared to SEK 30.33 million a year ago. Basic loss per share from continuing operations was SEK 0.2 compared to SEK 0.35 a year ago. Diluted loss per share from continuing operations was SEK 0.2 compared to SEK 0.35 a year ago.